‘Stopping antidepressants or not?’ New research says collaborative primary care planning between GPs and patients is key to decisions around prescribing and cessation.
Deprescribing campaign focuses on environmental gains Advocacy backed by the RACGP highlights the benefits of deprescribing to both patients and the planet.
RACGP endorses ‘landmark’ safe deprescribing guide Limited guidance on safely stopping antidepressants is being addressed as new advice for Australian general practice gets the green light.
Only 29% of clinical guidelines offer advice on deprescribing Researchers believe clinicians should have more support, but a prominent GP says numerous barriers make this a difficult proposition.
‘Could these medicines be doing more harm than good?’ Australian medical groups are asking clinicians this question as part of a push towards reducing polypharmacy.
Antidepressant withdrawal: The hidden danger New benchmark guidelines highlight the dangers of antidepressant withdrawal and support GPs in safe deprescribing.
Help needed to navigate ‘complex’ end-of-life care: RACGP Investing in care coordinators and identifying gaps in access are among the keys to quality end-of-life care, a college submission to the ACSQHC suggests.
Insights into weaning patients off antidepressants Discontinuing long-term antidepressant use should only occur after thorough preparation between a patient and their GP, new research has found.
GPs can help patients manage chronic non-cancer pain – with fewer opioids Opioids are no longer a front-line treatment for chronic non-cancer pain.